window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Diagnostics

  • Artificial Intelligence,Diagnostics,Digital Health,Medical devices,Women's Health

    Diagnoly launches Fetoly on iOS for real-time fetal ultrasound AI

    Diagnoly has launched its fetal ultrasound AI tool Fetoly on [...]

    April 7, 2026
  • Diagnostics,Drug discovery,Manufacturing,Research & Development,Technology and platforms

    Thermo Fisher launches Glacios 3 cryo-TEM to expand access to structural biology imaging

    Thermo Fisher Scientific has launched the Thermo Scientific Glacios 3 [...]

    April 2, 2026
  • Diagnostics,Gastroenterology,Genomics and sequencing,Partnerships & Funding,Technology and platforms

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    March 25, 2026
  • Diagnostics,Oncology,Partnerships & Funding

    SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics

    SPT Labtech has entered a strategic collaboration with Illumina to [...]

    February 27, 2026
  • Diagnostics,Genomics and sequencing,Research & Development,Technology and platforms

    New England Biolabs launches Monarch Mag Cell-free DNA extraction kit for scalable cfDNA isolation

    New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

    February 15, 2026
  • Artificial Intelligence,Clinical Trials,Diagnostics,Oncology

    SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials

    SpotitEarly has entered into a strategic research partnership with Fox [...]

    February 5, 2026
  • Diagnostics,Hematology,Oncology,Real world evidence

    Quest Diagnostics launches flow cytometry MRD blood test for myeloma to support ultrasensitive monitoring

    Quest Diagnostics has introduced a new blood-based test for measurable [...]

    February 4, 2026
  • Diagnostics,Infectious Diseases,Medical devices,Technology and platforms

    En Carta Diagnostics receives FDA breakthrough device designation for Lyme disease test

    En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]

    January 30, 2026
  • Diagnostics,Facilities and infrastructure,Oncology,Precision medicine,Research & Development

    Vortex Biotech opens new laboratory at Manchester Science Park to expand liquid biopsy development

    Vortex Biotech Holdings has opened a new laboratory facility at [...]

    January 27, 2026
  • Artificial Intelligence,Biotech,Clinical Trials,Diagnostics,Oncology,Precision medicine,Research & Development,Technology and platforms

    SpotitEarly announces strategic partnership with Fox Chase Cancer Center to advance early cancer detection

    SpotitEarly has formed a strategic partnership with Fox Chase Cancer [...]

    January 21, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top